Company profile
Chemed Corporation
NYSE: CHE · Healthcare · Medical - Care Facilities
#100 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
89AFH 88DQ 97GM 74SS 96
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ growth stability, balance-sheet leverage
Methodology →Revenue TTM
$2.5B
Rev growth YoY (TTM)
+2.1%
Net income (FY)
$265.2M
Employees
15,811
as of 2026-08-06
Market cap
$7.1B
as of 2026-08-06
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.5B$2.5B2025
Net income$265.2M$265.2M2025
Operating income$338.2M$338.2M2025
Total assets$1.5B$1.5B2025
Liabilities$558.8M$558.8M2025
Equity$979.4M$979.4M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Segment Vitas64%
Segment Roto Rooter36%
By geography
Not disclosed.
The read
What is Chemed Corporation’s revenue?
Chemed Corporation booked $2.5B in FY2025 revenue, growing 65% year over year — faster than most Healthcare companies we track, at a 10.5% net margin.
Peers · Healthcare
Insulet Corp.83B+Bio-Rad Laboratories, Inc.84B+Medpace Holdings, Inc.84B+Teladoc Health, Inc.70BAveanna Healthcare Holdings Inc.66BRoyalty Pharma plc72BNeighbors
Hamilton →Key facts
CEOKevin J. McNamara
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersCincinnati, OH
ExchangeNYSE: CHE
Employees15,811
IPO date1973-05-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.